| Mutations of the BRAF gene in human cancer H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg, J Teague, ... Nature 417 (6892), 949-954, 2002 | 12655 | 2002 |
| BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma M Colombino, M Capone, A Lissia, A Cossu, C Rubino, V De Giorgi, ... Journal of Clinical Oncology 30, 2522-2529, 2012 | 551 | 2012 |
| Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer C Jones, A Mackay, A Grigoriadis, A Cossu, JS Reis-Filho, L Fulford, ... Cancer research 64 (9), 3037-3045, 2004 | 326 | 2004 |
| Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis A D'Angelo, L Garzia, A André, P Carotenuto, V Aglio, O Guardiola, ... Cancer cell 5 (2), 137-149, 2004 | 163 | 2004 |
| X-inactivation patch size in human female tissue confounds the assessment of tumor clonality M Novelli, A Cossu, D Oukrif, A Quaglia, S Lakhani, R Poulsom, P Sasieni, ... Proceedings of the National Academy of Sciences 100 (6), 3311-3314, 2003 | 159 | 2003 |
| A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis P Liu, M Ge, J Hu, X Li, L Che, K Sun, L Cheng, Y Huang, MG Pilo, ... Hepatology 66 (1), 167-181, 2017 | 154 | 2017 |
| Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer SS Fois, P Paliogiannis, A Zinellu, AG Fois, A Cossu, G Palmieri International journal of molecular sciences 22 (2), 612, 2021 | 118 | 2021 |
| Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets G Palmieri, MN Ombra, M Colombino, M Casula, MC Sini, A Manca, ... Frontiers in oncology 5, 183, 2015 | 118 | 2015 |
| Neuroendocrine carcinoma within lymph nodes in the absence of a primary tumor, with special reference to Merkel cell carcinoma V Eusebi, C Capella, A Cossu, J Rosai The American journal of surgical pathology 16 (7), 658-666, 1992 | 118 | 1992 |
| Prognostic value of circulating melanoma cells detected by reverse transcriptase–polymerase chain reaction G Palmieri, PA Ascierto, F Perrone, SMR Satriano, A Ottaiano, A Daponte, ... Journal of clinical oncology 21 (5), 767-773, 2003 | 103 | 2003 |
| Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer P Baldinu, A Cossu, A Manca, MP Satta, MC Sini, C Rozzo, S Dessole, ... Human mutation 23 (4), 318-326, 2004 | 100 | 2004 |
| Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice S Zhang, X Song, D Cao, Z Xu, B Fan, L Che, J Hu, B Chen, M Dong, ... Journal of hepatology 67 (6), 1194-1203, 2017 | 96 | 2017 |
| The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism A Spanu, A Falchi, A Manca, P Marongiu, A Cossu, N Pisu, F Chessa, ... Journal of Nuclear Medicine 45 (1), 40-48, 2004 | 93 | 2004 |
| Distribution and significance of 14‐3‐3σ, a novel myoepithelial marker, in normal, benign, and malignant breast tissue PT Simpson, T Gale, JS Reis‐Filho, C Jones, S Parry, D Steele, A Cossu, ... The Journal of pathology 202 (3), 274-285, 2004 | 92 | 2004 |
| Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia LA Vaira, C Hopkins, A Sandison, A Manca, N Machouchas, D Turilli, ... The Journal of Laryngology & Otology 134 (12), 1123-1127, 2020 | 84 | 2020 |
| Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay G Palmieri, PA Ascierto, A Cossu, N Mozzillo, ML Motti, SMR Satriano, ... Journal of clinical oncology 19 (5), 1437-1443, 2001 | 73 | 2001 |
| Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma M Colombino, A Cossu, A Manca, MF Dedola, M Giordano, F Scintu, ... Annals of oncology 13 (9), 1447-1453, 2002 | 70 | 2002 |
| Molecular pathways in melanomagenesis: what we learned from next-generation sequencing approaches G Palmieri, M Colombino, M Casula, A Manca, M Mandalà, A Cossu, ... Current oncology reports 20, 1-16, 2018 | 68 | 2018 |
| Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases F Carta, PP Demuro, C Zanini, A Santona, D Castiglia, S D'Atri, ... Melanoma research 15 (4), 235-244, 2005 | 67 | 2005 |
| Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma X Song, X Liu, H Wang, J Wang, Y Qiao, A Cigliano, K Utpatel, S Ribback, ... Clinical Cancer Research 25 (1), 403-413, 2019 | 66 | 2019 |
